TDNAvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with TDNA, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
TDNA performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TDNA ETF 2 | +0.68%– | n/a– | n/a– | n/a– | n/a– | n/a– |
| Flows | TDNA ETF 2 | +$568K– | -– | -– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TDNA ETF 2 | n/a– | n/a– | n/a– | n/a– |
| Max drawdown | TDNA ETF 2 | n/a– | n/a– | n/a– | n/a– |
| Max drawdown duration | TDNA ETF 2 | n/a– | n/a– | n/a– | n/a– |
Trading data
TDNA | ETF 2 | |
Last sale 10/30/2026 at 1:30 PM | $24.89 | – |
| Previous close 10/29/2026 | $25.17 | – |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
TDNA | ETF 2 | |
|---|---|---|
| Last price | $24.89 | – |
| 1D performance | -1.11% | – |
| AuM | $10.69 M | – |
| E/R | 0.55% | – |
Characteristics
TDNA | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | T. Rowe Price | – |
| Benchmark | - | – |
| N° of holdings | 86 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 16, 2026 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
TDNA
USA
88.46%
Other
11.54%
ETF 2
Sectors
TDNA
Healthcare
98.5%
Other
1.5%
ETF 2
Advertisement
Diversification
TDNA
Total weight of top 15 holdings out of 15
37.16%
ETF 2
–
Top 15 holdings
Data as of September 30, 2026
TDNA
argenx SE
5.41%
Kymera Therapeutics, Inc.
4.04%
Kodiak Sciences, Inc.
2.68%
Insmed, Inc.
2.59%
Natera, Inc.
2.41%
Revolution Medicines, Inc.
2.37%
Vertex Pharmaceuticals, Inc.
2.25%
United Therapeutics Corp.
2.20%
Alnylam Pharmaceuticals, Inc.
1.98%
Dianthus Therapeutics, Inc.
1.91%
Praxis Precision Medicines, Inc.
1.91%
Moderna, Inc.
1.90%
Vaxcyte, Inc.
1.86%
Cytokinetics, Inc.
1.83%
Rhythm Pharmaceuticals, Inc.
1.81%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
